Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.929 USD | -3.74% | -17.11% | -34.28% |
05-09 | Oppenheimer Adjusts Seres Therapeutics Price Target to $4 From $5, Maintains Outperform Rating | MT |
05-09 | Chardan Adjusts Price Target on Seres Therapeutics to $6 From $8, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.28% | 146M | |
+4.56% | 111B | |
+11.07% | 105B | |
-12.28% | 22.34B | |
-3.58% | 21.93B | |
-6.13% | 18.59B | |
-35.21% | 18.12B | |
-9.38% | 16.96B | |
+3.22% | 13.7B | |
+36.43% | 12.45B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Seres Therapeutics : HC Wainwright Adjusts Seres Therapeutics' Price Target to $46 From $41, Maintains Buy Rating